Drug & Supplement Interactions

Psilocybin + Memantine

Brand names of Memantine

  • Namenda
  • Ebixa
  • Namenda XR

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated October 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Best Avoided

We found no known interaction between Psilocybin and Memantine in our sources, but our pharmacy team rates Psilocybin itself best avoided. Psilocybin is a controlled substance with powerful mind-altering effects and is not a safe or legal dietary supplement.

This also applies to Namenda, Ebixa and Namenda XR, brand names of memantine.

Still Worth Knowing

  • Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Psilocybin with Memantine. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Psilocybin and Memantine Interaction Check

No Known Interaction, but Psilocybin Is Best Avoided

We did not find a documented interaction between Memantine and Psilocybin in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Our pharmacy team rates Psilocybin best avoided, whatever else you take. Psilocybin is a controlled substance with powerful mind-altering effects and is not a safe or legal dietary supplement. See Psilocybin’s safety ratings →

How We Checked

Why No Interaction Is Listed for Memantine

We sort drugs into categories, such as blood thinners or antibiotics, and many supplement interactions are recorded for a whole category rather than for one drug. So we checked every category Memantine is in against every category Psilocybin has a known interaction with.

2Categories Memantine Is In
  • Nmda Antagonists No Psilocybin Record
  • Oral Drugs Any drug taken by mouth. No Psilocybin Record
2Drug Categories Psilocybin Interacts With

No overlap. Memantine is in none of the 2 categories Psilocybin interacts with, so no record links the two.

Still wondering about combining Psilocybin and Memantine? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

Side Effects Psilocybin and Memantine Have in Common

11 side effects show up for both Psilocybin and Memantine.

  • Each has separately been linked to the effects below. Taken together, they might add up: the same side effect from two sources might be more likely or stronger. No study of the two together says by how much.
  • If one turns up, it can be harder to tell which one is behind it, so tell your pharmacist you take both.
  • 5 of them are worth acting on rather than waiting out, marked below.
  • Hallucinations / Confusion Worth Acting On reported in 5.5% of FDA reports for Memantine Additional detail

    Psilocybin

    Psilocybin has psychedelic or hallucinogenic effects, with side effects including visual, auditory, tactile, and other illusions, as well as changes in time and space perception, and "mystical experiences". The severity of some of these responses may be dose-dependent.

    Source: , the clinical database we license.

    6 references cited
    1. 106129. Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 2016;30(12):1181-1197. PubMed
    2. 106137. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 2015;29(3):289-99. PubMed
    3. 106138. Grob CS, Danforth AL, Chopra GS, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 2011;68(1):71-8. PubMed
    4. 106146. Brown RT, Nicholas CR, Cozzi NV, et al. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. Clin Pharmacokinet 2017;56(12):1543-1554. PubMed
    5. 106150. Griffiths RR, Johnson MW, Richards WA, et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial at
    6. 106154. Carbonaro TM, Bradstreet MP, Barrett FS, et al. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. J Psychopharmacol 2016;30(12):1268-1278. PubMed

    Memantine

    Source: Memantine’s

    It lists this side effect in its Adverse Reactions section. Voluntary reports to the FDA mention it too.

    Read Memantine’s label on DailyMed ›
  • Thoughts of self-harm Worth Acting On Additional detail

    Psilocybin

    Recorded for Psilocybin in the same Natural Medicines adverse-effect record shown under Hallucinations / Confusion above.

    Memantine

    Source: Memantine’s

    It lists this side effect in its Adverse Reactions section.

    Read Memantine’s label on DailyMed ›
  • Seizures Worth Acting On Additional detail

    Psilocybin

    Orally, single doses of psilocybin have resulted in mild to moderate headache in numerous case studies and experimental studies. Headaches have been reported in up to 50% of individuals, starting a mean of 7 hours after intake and lasting for 1-2 days. Severity and duration seem to be dose-dependent.

    Source: , the clinical database we license.

    6 references cited
    1. 106129. Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 2016;30(12):1181-1197. PubMed
    2. 106131. Carhart-Harris RL, Bolstridge M, Day CMJ, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl) 2018;235(2):399-408. PubMed
    3. 106132. Ross S, Bossis A, Guss J, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 2016;30(12):1165-1180. PubMed
    4. 106134. Carhart-Harris RL, Bolstridge M, Rucker J, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 2016;3(7):619-27. PubMed
    5. 106135. Davis AK, Barrett FS, May DG, et al. Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry 2021;78(5):481-489. PubMed
    6. 106137. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 2015;29(3):289-99. PubMed

    Severe rhabdomyolysis, followed by acute kidney failure and posterior encephalopathy resulting in short-term vision loss, disorientation, agitation, and seizures has been reported in a 25-year-old male following use of an unknown quantity of Psilocybe cubensis mushrooms.

    Source: , the clinical database we license.

    2 references cited
    1. 106181. Bickel M, Ditting T, Watz H, et al. Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse. Eur J Emerg Med 2005;12(6):306-8. PubMed
    2. 110795. Suleiman M, Basu A, Belal S, Jacob T. From mushrooms to myolysis: A case of rhabdo in psilocybin-induced mood and psychotic disorder. J Nerv Ment Dis 2022;210(8):638-639. PubMed

    Memantine

    Source: Memantine’s

    It lists this side effect in its Adverse Reactions section.

    Read Memantine’s label on DailyMed ›
  • Kidney problems Worth Acting On Additional detail

    Psilocybin

    Recorded for Psilocybin in the same Natural Medicines adverse-effect record shown under Hallucinations / Confusion above.

    Memantine

    Source: Memantine’s

    It lists this side effect in its Adverse Reactions section.

    Read Memantine’s label on DailyMed ›
  • Raised blood pressure Worth Acting On Additional detail

    Psilocybin

    Recorded for Psilocybin in the same Natural Medicines adverse-effect record shown under Hallucinations / Confusion above.

    Memantine

    Source: Memantine’s

    It lists this side effect in its Adverse Reactions section.

    Read Memantine’s label on DailyMed ›
  • Drowsiness / Dizziness reported in 3.7% of FDA reports for Memantine Additional detail

    Psilocybin

    Recorded for Psilocybin in the same Natural Medicines adverse-effect record shown under Seizures above.

    Memantine

    Source: Memantine’s

    It lists this side effect in its Adverse Reactions section. Voluntary reports to the FDA mention it too.

    Read Memantine’s label on DailyMed ›
  • Tiredness reported in 4.8% of FDA reports for Memantine Additional detail

    Psilocybin

    Orally, single doses of psilocybin have resulted in unspecified types of physical discomfort, abnormal feelings, and fatigue.

    Source: , the clinical database we license.

    2 references cited
    1. 106129. Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 2016;30(12):1181-1197. PubMed
    2. 113870. Peck SK, Shao S, Gruen T, et al. Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study. Nat Med 2023;29(8):1947-1953. PubMed

    Memantine

    Source: Memantine’s

    It lists this side effect in its Adverse Reactions section. Voluntary reports to the FDA mention it too.

    Read Memantine’s label on DailyMed ›
  • Vomiting Additional detail

    Psilocybin

    Orally, single doses of psilocybin have resulted in nausea, and rarely, vomiting and diarrhea. Analysis from a large clinical trial that evaluated single doses of psilocybin 1 mg, 10 mg, and 25 mg suggests that for every 5 patients treated with psilocybin 25 mg over psilocybin 1 mg, one additional case of nausea will occur.

    Source: , the clinical database we license.

    6 references cited
    1. 106129. Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 2016;30(12):1181-1197. PubMed
    2. 106131. Carhart-Harris RL, Bolstridge M, Day CMJ, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl) 2018;235(2):399-408. PubMed
    3. 106132. Ross S, Bossis A, Guss J, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 2016;30(12):1165-1180. PubMed
    4. 106134. Carhart-Harris RL, Bolstridge M, Rucker J, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 2016;3(7):619-27. PubMed
    5. 106137. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 2015;29(3):289-99. PubMed
    6. 106161. Carbonaro TM, Johnson MW, Griffiths RR. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan. Psychopharmacology (Berl) 2020;237(8):2293-2304. PubMed

    Memantine

    Source: Memantine’s

    It lists this side effect in its Adverse Reactions section.

    Read Memantine’s label on DailyMed ›

Showing the 10 most notable of 11 shared effects — ranked by how unusual each one is, not just whether both lists mention it.

Reported for Psilocybin but not commonly for Memantine: a heart attack, a slow heartbeat, dependence or withdrawal symptoms and mood changes or irritability.

Note: Effects for Memantine come from the Adverse Reactions section of its FDA label; effects for Psilocybin come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 14,609 voluntary FDA FAERS reports for Memantine that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. The two sources word some effects differently, so we match them by meaning.

If You Already Take Both
  • Tell your pharmacist or doctor that you take Psilocybin, so they can check it against everything else you take.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.
Published Research

Has Anyone Studied Psilocybin With Memantine?

lists 1 record naming both, but none of them looks at the two together. It is listed below. Most supplement and drug pairs have never been studied together.

The Record PubMed Found

It names both, but never in the same sentence or only in a lab method, so it may be about something else.

  1. The Black Book of Psychotropic Dosing and Monitoring. Psychopharmacology Bulletin · 2024 · Review · In people · PMID 38993656

Reports to the FDA

We found no report in the FDA’s Adverse Event Reporting System (FAERS) that lists both Psilocybin and Memantine. Supplements are often left off these reports, so none found does not mean nothing has happened.

How we searched

PubMed: searched November 2026, and again every few months. PubMed lists research but does not grade it; the finding above comes from our interaction records.

FDA reports: from the FDA Adverse Event Reporting System (FAERS) through openFDA, read November 2026. Matched by name, so a report may name a product that contains Psilocybin. The counts are reports, not people, and no one checks them for cause. What FAERS is.

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Psilocybin Does Interact With Other Medications

Psilocybin has 293 moderate known drug interactions in our database — Memantine isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Psilocybin

Covers the 2,830 medications we’ve checked against Psilocybin. Pick one to open its full report.

Alternatives for the Same Use

Other Supplements Studied for Depression, and How They Mix With Memantine

Choosing a supplement while you take Memantine? Here are other options studied for depression, and whether each has a documented interaction with Memantine.

None of them has a documented interaction with Memantine.

10 other supplements have at least some evidence of a benefit for depression; the 8 below come first. Psilocybin itself is graded for it.

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

Everything Else You Take

See Every Supplement That Interacts With Memantine

Take other supplements too? 18 supplements have a documented interaction with Memantine, each explained on its page.

By severity: 2 major, 7 moderate and 9 minor.

The Most Serious There Right Now:

Open the Memantine interaction pageEvery supplement checked against Memantine, ranked by severity

Get to Know Each One

About Psilocybin and Memantine

Supplement

About Psilocybin

Psilocybin is a powerful psychedelic compound found in certain mushrooms and is being studied for hard-to-treat depression, anxiety, and addiction, but it is still investigational and not an approved supplement. It is illegal in most places, can cause intense and unpredictable mental effects, and should never be used outside of a supervised clinical setting.

Full Psilocybin guide: uses, dosage, safety and every interaction
Safety at a Glance

How Psilocybin Is Rated

  • Psilocybin Overall

    Avoid

    Psilocybin is a controlled substance with powerful mind-altering effects and is not a safe or legal dietary supplement.

  • Pregnancy

    Avoid

    There is no safety data; avoid during pregnancy.

  • Breastfeeding

    Avoid

    There is no safety data; avoid while breastfeeding.

Medication

About Memantine

Brand names: Namenda, Ebixa, Namenda XR

Memantine treats moderate to severe dementia of the Alzheimer’s type. Every product covered here has this same use: the tablets, the oral solution and the extended-release capsules.

Memantine: uses, dosage and side effects Memantine: interactions with other drugs Taking more than these two? Check Psilocybin and Memantine with everything else you take Memantine Hydrochloride NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Psilocybin

Browse every other medication we’ve checked against Psilocybin — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
293Moderate
0Minor
2,536No known interaction
Moderate

Moderate: 293 interactions

Showing 60 of 293 moderate interactions — see all 293 on the Psilocybin page.

No Interaction 2,536 drugs checked — show the list

We also checked Psilocybin against these medications and found no known interaction in our sources. Open any page to confirm.

Showing 60 of the 2,536 medications checked with no known interaction, the most looked-up first — see the full Psilocybin list.

How Much People Look This Up

Where Psilocybin and Memantine Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Psilocybin
Top 25%

#228 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Memantine
Top 25%

#447 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Psilocybin and Memantine Together: Common Questions

Can you take Psilocybin with Memantine?
We do not list a known interaction between Psilocybin and Memantine, but that is not a reason to take Psilocybin: our pharmacy team rates it best avoided, whatever else you take. Psilocybin is a controlled substance with powerful mind-altering effects and is not a safe or legal dietary supplement. Talk with your pharmacist or doctor before taking it, and do not stop or change Memantine on your own.
Can you take Psilocybin with Namenda?
Namenda is a brand name of memantine, and so are Ebixa and Namenda XR, so the answer is the same as for memantine. We do not list a known interaction between Psilocybin and Memantine, but that is not a reason to take Psilocybin: our pharmacy team rates it best avoided, whatever else you take. Everything on this page applies to Namenda too.
Do Psilocybin and Memantine have any of the same side effects?
Yes — our sources link each of them separately to 10 of the same effects. That is not a documented interaction, but taken together the same side effect from two sources might be more likely or stronger; no study of the two together says by how much. And if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
How was the Psilocybin and Memantine combination checked?
Interactions in our licensed database are recorded against drug classes. Memantine is filed under 2 classifications, and Psilocybin has documented interactions with 2 drug classes — none of Memantine's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Do other supplements studied for depression interact with Memantine?
None of the 10 other supplements the Natural Medicines database grades as having some evidence of a benefit for depression has a documented interaction with Memantine. A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.
Does Psilocybin interact with any other medications?
Yes. Psilocybin has 293 documented drug interactions in our database — Memantine is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Memantine interact with any supplements?
Yes. Memantine has documented interactions with 18 supplements in our database — Psilocybin is not one of them. The Memantine interaction page linked on this page lists every one, ranked by severity.
Has Psilocybin been studied with Memantine?
We searched PubMed, the National Library of Medicine's index of medical research, in November 2026. It lists 1 record that name both Psilocybin and Memantine, but none of the most relevant discusses the two together. The records it found are listed on this page, with links to PubMed.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 14 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 14 references
  1. 106129. Griffiths RR, Johnson MW, Carducci MA, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol 2016;30(12):1181-1197. PubMed
  2. 106131. Carhart-Harris RL, Bolstridge M, Day CMJ, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl) 2018;235(2):399-408. PubMed
  3. 106132. Ross S, Bossis A, Guss J, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 2016;30(12):1165-1180. PubMed
  4. 106134. Carhart-Harris RL, Bolstridge M, Rucker J, et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 2016;3(7):619-27. PubMed
  5. 106135. Davis AK, Barrett FS, May DG, et al. Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry 2021;78(5):481-489. PubMed
  6. 106137. Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol 2015;29(3):289-99. PubMed
  7. 106138. Grob CS, Danforth AL, Chopra GS, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 2011;68(1):71-8. PubMed
  8. 106146. Brown RT, Nicholas CR, Cozzi NV, et al. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. Clin Pharmacokinet 2017;56(12):1543-1554. PubMed
  9. 106150. Griffiths RR, Johnson MW, Richards WA, et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial at
  10. 106154. Carbonaro TM, Bradstreet MP, Barrett FS, et al. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. J Psychopharmacol 2016;30(12):1268-1278. PubMed
  11. 106161. Carbonaro TM, Johnson MW, Griffiths RR. Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan. Psychopharmacology (Berl) 2020;237(8):2293-2304. PubMed
  12. 106181. Bickel M, Ditting T, Watz H, et al. Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse. Eur J Emerg Med 2005;12(6):306-8. PubMed
  13. 110795. Suleiman M, Basu A, Belal S, Jacob T. From mushrooms to myolysis: A case of rhabdo in psilocybin-induced mood and psychotic disorder. J Nerv Ment Dis 2022;210(8):638-639. PubMed
  14. 113870. Peck SK, Shao S, Gruen T, et al. Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study. Nat Med 2023;29(8):1947-1953. PubMed

All 65 references behind our Psilocybin records are listed in the Psilocybin guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The Psilocybin and Memantine records this page draws on were last updated October 20, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Psilocybin and Memantine?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.